Pfizer Inc. (PFE): Price and Financial Metrics

Pfizer Inc. (PFE): $53.76

-0.35 (-0.65%)

POWR Rating

Component Grades














  • PFE scores best on the Growth dimension, with a Growth rank ahead of 97.19% of US stocks.
  • PFE's strongest trending metric is Growth; it's been moving up over the last 160 days.
  • PFE ranks lowest in Momentum; there it ranks in the 11th percentile.

PFE Stock Summary

  • PFE has a higher market value than 99.52% of US stocks; more precisely, its current market capitalization is $303,712,211,618.
  • PFE's went public 36.07 years ago, making it older than 92.74% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of -36.85%, Pfizer Inc's debt growth rate surpasses only 13.22% of about US stocks.
  • Stocks that are quantitatively similar to PFE, based on their financial statements, market capitalization, and price volatility, are ASML, XOM, DIS, TM, and KO.
  • PFE's SEC filings can be seen here. And to visit Pfizer Inc's official web site, go to

PFE Valuation Summary

  • PFE's price/sales ratio is 5; this is 55.95% lower than that of the median Healthcare stock.
  • PFE's price/sales ratio has moved down 2.9 over the prior 243 months.
  • Over the past 243 months, PFE's price/earnings ratio has gone down 17.6.

Below are key valuation metrics over time for PFE.

Stock Date P/S P/B P/E EV/EBIT
PFE 2021-08-31 5.0 3.7 19.5 20.3
PFE 2021-08-30 5.1 3.7 19.8 20.5
PFE 2021-08-27 5.1 3.7 19.8 20.5
PFE 2021-08-26 5.1 3.8 20.1 20.8
PFE 2021-08-25 5.2 3.8 20.1 20.8
PFE 2021-08-24 5.3 3.9 20.5 21.2

PFE Growth Metrics

    Its 3 year cash and equivalents growth rate is now at -24.37%.
  • The 2 year revenue growth rate now stands at -3.82%.
  • Its 5 year cash and equivalents growth rate is now at -16.01%.
Over the past 49 months, PFE's revenue has gone up $11,129,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 63,600 32,291 19,180
2021-06-30 51,637 23,552 13,228
2021-03-31 44,461 15,808 11,091
2020-12-31 41,908 14,403 9,616
2020-09-30 48,648 12,547 8,685
2020-06-30 49,197 14,967 14,171

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
  • PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
  • XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.312 0.704 0.149
2021-04-04 0.265 0.763 0.116
2020-12-31 0.247 0.793 0.099
2020-09-27 0.282 0.799 0.083
2020-06-28 0.288 0.799 0.181
2020-03-29 0.307 0.799 0.200

PFE Price Target

For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $46.03 Average Broker Recommendation 1.8 (Hold)

PFE Stock Price Chart Interactive Chart >

Price chart for PFE

PFE Price/Volume Stats

Current price $53.76 52-week high $61.71
Prev. close $54.11 52-week low $33.36
Day low $53.49 Volume 13,035,750
Day high $54.49 Avg. volume 36,664,484
50-day MA $54.36 Dividend yield 2.88%
200-day MA $45.06 Market Cap 301.75B

Pfizer Inc. (PFE) Company Bio

Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.

PFE Latest News Stream

Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about Pfizer Inc that investors may wish to consider to help them evaluate PFE as an investment opportunity.

Smith & Howard Wealth Management, LLC Buys iShares National Muni Bond ETF, Vanguard ...

Atlanta, GA, based Investment company Smith & Howard Wealth Management, LLC (Current Portfolio) buys iShares National Muni Bond ETF, Vanguard Short-Term Government Bond ETF, ISHARES TRUST, iShares Short-Term National Muni Bond ETF, Vanguard Large Cap ETF, sells Schwab Short-Term U.S.

Yahoo | January 18, 2022

This New Study Suggests Pfizer, BioNTech Are Losing The Omicron Battle

A fourth dose of Pfizer and BioNTech's Covid shot is only partly effective against omicron, according to a new test. The vaccine stocks fell.

Yahoo | January 18, 2022

Omicron cases are falling in some parts of the country, hospitalizations rise

Yahoo Finance's Anjalee Khemlani discusses the latest on Omicron cases, COVID-19 hospitalizations, and the White House's initiative to distribute free at-home coronavirus testing.

Yahoo | January 18, 2022

Omicron: Why a fourth dose of coronavirus vaccines may not be 'absolutely necessary,' doctor says

Dr. Robert G. Lahita MD, PhD, Director of the Institute for Autoimmune and Rheumatic Disease at Saint Joseph Health and author of Immunity Strong, joins Yahoo Finance Live to discuss the latest information on COVID-19 booster vaccinations, transmissibility, and the pressures felt by hospitals in remote regions.

Yahoo | January 18, 2022

Why You Should Invest in Dividend Growth ETFs Now

We highlight 3 ultra-cheap ETFs that focus on high quality dividend payers

Yahoo | January 18, 2022

Read More 'PFE' Stories Here

PFE Price Returns

1-mo -11.90%
3-mo 26.53%
6-mo 31.29%
1-year 52.09%
3-year 49.68%
5-year 115.70%
YTD -8.96%
2021 66.69%
2020 3.23%
2019 -6.91%
2018 24.82%
2017 15.90%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8584 seconds.